623 related articles for article (PubMed ID: 16342192)
1. The acute phase reactant, fibrinogen, as a guide to plasma exchange therapy for acute Guillain-Barré syndrome.
Sanjay R; Flanagan J; Sodano D; Gorson KC; Ropper AH; Weinstein R
J Clin Apher; 2006 Jul; 21(2):105-10. PubMed ID: 16342192
[TBL] [Abstract][Full Text] [Related]
2. Guillain-Barré syndrome treated by membrane plasma exchange and/or immunoadsorption.
Marn Pernat A; Buturović-Ponikvar J; Svigelj V; Ponikvar R
Ther Apher Dial; 2009 Aug; 13(4):310-3. PubMed ID: 19695065
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic plasma exchange in patients with neurologic diseases: retrospective multicenter study.
Kaynar L; Altuntas F; Aydogdu I; Turgut B; Kocyigit I; Hacioglu SK; Ismailogullari S; Turgut N; Erkurt MA; Sari I; Oztekin M; Solmaz M; Eser B; Ersoy AO; Unal A; Cetin M
Transfus Apher Sci; 2008 Apr; 38(2):109-15. PubMed ID: 18331814
[TBL] [Abstract][Full Text] [Related]
4. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group.
van der Meché FG; Schmitz PI
N Engl J Med; 1992 Apr; 326(17):1123-9. PubMed ID: 1552913
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy for Guillain-Barré syndrome in the US hospitals.
Alshekhlee A; Hussain Z; Sultan B; Katirji B
J Clin Neuromuscul Dis; 2008 Sep; 10(1):4-10. PubMed ID: 18772694
[TBL] [Abstract][Full Text] [Related]
6. Factors influencing outcome in Guillain-Barré Syndrome: comparison of plasma adsorption against other treatments.
Seta T; Nagayama H; Katsura K; Hamamoto M; Araki T; Yokochi M; Utsumi K; Katayama Y
Clin Neurol Neurosurg; 2005 Oct; 107(6):491-6. PubMed ID: 16202823
[TBL] [Abstract][Full Text] [Related]
7. Plasma exchange after initial intravenous immunoglobulin treatment in Guillain-Barré syndrome: critical reassessment of effectiveness and cost-efficiency.
Oczko-Walker M; Manousakis G; Wang S; Malter JS; Waclawik AJ
J Clin Neuromuscul Dis; 2010 Dec; 12(2):55-61. PubMed ID: 21386771
[TBL] [Abstract][Full Text] [Related]
8. Plasmapheresis treatment in Guillain-Barré syndrome: potential benefit over IVIg in patients with axonal involvement.
Dada MA; Kaplan AA
Ther Apher Dial; 2004 Oct; 8(5):409-12. PubMed ID: 15663537
[TBL] [Abstract][Full Text] [Related]
9. Physiological changes during and outcome following 'filtration' based continuous plasma exchange in Guillain Barre Syndrome.
Jayasena YA; Mudalige SP; Manchanayake GS; Dharmapala HL; Kumarasiri RP; Weerasinghe VS; Goonasekera CD
Transfus Apher Sci; 2010 Apr; 42(2):109-13. PubMed ID: 20122871
[TBL] [Abstract][Full Text] [Related]
10. Efficiency of plasma exchange in Guillain-Barré syndrome: role of replacement fluids. French Cooperative Group on Plasma Exchange in Guillain-Barré syndrome.
Ann Neurol; 1987 Dec; 22(6):753-61. PubMed ID: 2893583
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis of Guillain-Barré syndrome and validation of Brighton criteria.
Fokke C; van den Berg B; Drenthen J; Walgaard C; van Doorn PA; Jacobs BC
Brain; 2014 Jan; 137(Pt 1):33-43. PubMed ID: 24163275
[TBL] [Abstract][Full Text] [Related]
12. [Immunoadsorption therapy with TR-350 (tryptophan column) for Guillain-Barré syndrome: investigation including serum antiganglioside antibody assay].
Araki T; Nakata H; Kusunoki S; Arai Y; Katayama Y
Rinsho Shinkeigaku; 2000 Oct; 40(10):979-85. PubMed ID: 11296374
[TBL] [Abstract][Full Text] [Related]
13. Plasma cortisol levels in Guillain-Barré syndrome.
Strauss J; Aboab J; Rottmann M; Porcher R; Polito A; Ikka L; Durand MC; Orlikowski D; Devaux C; Lofaso F; Annane D; Gaillard JL; Sharshar T
Crit Care Med; 2009 Aug; 37(8):2436-40. PubMed ID: 19531948
[TBL] [Abstract][Full Text] [Related]
14. Plasma exchange in elderly patients.
Basic-Jukic N; Brunetta B; Kes P
Ther Apher Dial; 2010 Apr; 14(2):161-5. PubMed ID: 20438537
[TBL] [Abstract][Full Text] [Related]
15. [Functional recovery in Guillain-Barre syndrome: benefits of plasma exchange].
Cassuto-Viguier E; Sanderson F; Kullman B; Quaranta JF; Montagne N; Gueyraud A; Therre C; Duplay H
Ann Med Interne (Paris); 1988; 139 Suppl 1():43-5. PubMed ID: 3247991
[TBL] [Abstract][Full Text] [Related]
16. Filtration of cerebrospinal fluid in acute inflammatory demyelinating polyneuropathy (Guillain-Barré syndrome).
Wollinsky KH; Hülser PJ; Brinkmeier H; Mehrkens HH; Kornhuber HH; Rüdel R
Ann Med Interne (Paris); 1994; 145(7):451-8. PubMed ID: 7864511
[TBL] [Abstract][Full Text] [Related]
17. Management and outcome of severe Guillain-Barré syndrome.
Ng KK; Howard RS; Fish DR; Hirsch NP; Wiles CM; Murray NM; Miller DH
QJM; 1995 Apr; 88(4):243-50. PubMed ID: 7796073
[TBL] [Abstract][Full Text] [Related]
18. Guillain-Barré syndrome--a patient guide and nursing resource.
Kehoe M
Axone; 2001 Jun; 22(4):16-24. PubMed ID: 14621501
[TBL] [Abstract][Full Text] [Related]
19. Tryptophan-immobilized column-based immunoadsorption as the choice method for plasmapheresis in Guillain-Barré syndrome.
Okamiya S; Ogino M; Ogino Y; Irie S; Kanazawa N; Saito T; Sakai F
Ther Apher Dial; 2004 Jun; 8(3):248-53. PubMed ID: 15154879
[TBL] [Abstract][Full Text] [Related]
20. Clinically diagnosed Guillain-Barre syndrome in Ile-Ife, Nigeria.
Sunmonu TA; Komolafe MA; Adewuya A; Olugbodi AA
West Afr J Med; 2008 Jul; 27(3):167-70. PubMed ID: 19256323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
